Health
CN Bio partners with Imperial College London to uncover therapeutic targets for alcoholic hepatitis – News-Medical.net
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems to improve the accuracy and efficiency of drug discovery, today announced a collaboration with Imperial College London, a world-class research univer…
CN Bio, a leading cell culture company, that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy and efficiency of drug discovery, today announced a collaboration with Imperial College London, a world-class research university. The research will harness CN Bio’s Liver-on-Chip technology to advance the understanding of the underlying mechanisms of alcoholic hepatitis and uncover novel targets for drug discovery and development.
Despite being an increasin…
-
General23 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General22 hours agoJaguar Land Rover in UK pauses shipments to US
-
General20 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoAustralian share market set to dive as threat of US recession grows